BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND GNAQ, P50148, 2776, ENSG00000156052, G-ALPHA-q, RP11-494N1_1, GAQ
64387 results:

  • 1. International Variations in Surgical Quality of Care in Men With prostate cancer: Results From the TrueNTH Global Registry.
    Sibert NT; Garin O; Ferrer M; Connor SE; Graham ID; Litwin MS; Millar J; Moore CM; Nguyen AV; Paich K; Kowalski C
    JCO Glob Oncol; 2024 May; 10():e2300420. PubMed ID: 38815192
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. prostate cancer Foundation Screening Guidelines for Black Men in the United States.
    Garraway IP; Carlsson SV; Nyame YA; Vassy JL; Chilov M; Fleming M; Frencher SK; George DJ; Kibel AS; King SA; Kittles R; Mahal BA; Pettaway CA; Rebbeck T; Rose B; Vince R; Winn RA; Yamoah K; Oh WK
    NEJM Evid; 2024 May; 3(5):EVIDoa2300289. PubMed ID: 38815168
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study).
    Parker LA; Caballero-Romeu JP; Chilet-Rosell E; Hernandez-Aguado I; Gómez-Pérez L; Alonso-Coello P; Cebrián A; López-Garrigós M; Moral-Pélaez I; Ronda E; Gilabert M; Canelo-Aybar C; Párraga-Martínez I; Del Campo-Giménez M; Lumbreras B
    PLoS One; 2024; 19(5):e0303203. PubMed ID: 38814917
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impacts of Chlorine 1-3 ıon channels on localized bladder neoplasms.
    Muslum O; Ahmet K; Ebru O; Ahmet T; Tunc O; Ahmet K; Irfan O
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):76-81. PubMed ID: 38814232
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
    Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
    Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data.
    Miao Q; Lei S; Chen F; Niu Q; Luo H; Cai B
    BMC Cancer; 2024 May; 24(1):657. PubMed ID: 38811867
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Membranous urethral length is the single independent predictor of urinary continence recovery at 12 months following Retzius-sparing robot-assisted radical prostatectomy.
    Fonseca J; Moraes-Fontes MF; Sousa I; Oliveira F; Froes G; Gaivão A; Palmas A; Rebola J; Muresan C; Santos T; Dias D; Varandas M; Lopez-Beltran A; Ribeiro R; Fraga A
    J Robot Surg; 2024 May; 18(1):230. PubMed ID: 38809307
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
    Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
    World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sexual satisfaction and its predictors in patients with advanced cancer and their family caregivers in six European countries: Baseline data from the DIAdIC study.
    Matthys O; Dierickx S; Van Goethem V; Deliens L; Lapeire L; De Pauw A; Hudson P; Vulsteke C; Geboes K; De Waele S; Spoormans I; Di Leo S; Guberti M; Schmidt US; Scott D; Harding R; Witkamp E; Connolly M; ; De Vleminck A; Cohen J
    Psychooncology; 2024 Jun; 33(6):e6347. PubMed ID: 38804579
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.
    Pirani E; Paparoditis P; Pecoraro M; Danelon G; Thelen M; Cecchinato V; Uguccioni M
    Front Immunol; 2024; 15():1358800. PubMed ID: 38803493
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high-volume center in Southeast China.
    Lin S; Jiang W; Ding J; Hao S; Chen H; Xie L; Zheng X
    World J Surg Oncol; 2024 May; 22(1):140. PubMed ID: 38802859
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Stage at diagnosis of prostate cancer in an institutional hospital. Review and comparison of national and international data].
    Pauchard F; Kramer F; Kirmayr M; Escobar M
    Rev Med Chil; 2023 Jun; 151(6):711-716. PubMed ID: 38801379
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
    Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies.
    Takanashi Y; Kahyo T; Sekihara K; Kawase A; Setou M; Funai K
    Lipids Health Dis; 2024 May; 23(1):154. PubMed ID: 38796445
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prostatic stromal tumor of uncertain malignant potential: a case report and literature review.
    Zhu T; Yin C; Liufu C; Jiang J; Luo J; Wang Y
    J Int Med Res; 2024 May; 52(5):3000605241253756. PubMed ID: 38796313
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant prostate cancer.
    Kim JH; Yang HJ; Lee SH; Song YS
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791557
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
    Williams A; Cooper E; Clark B; Perry L; Ponassi M; Iervasi E; Brullo C; Greenhough A; Ladomery M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791418
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of prostate cancer: A Critical Appraisal of the Literature Data.
    Fendler A; Stephan C; Ralla B; Jung K
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791324
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The impact of low pressure pneumoperitoneum in robotic assisted radical prostatectomy II: a prospective, randomized, double blinded trial.
    Keating K; Holdren C; Eames R; Pulford C; O'Pry E; Peifer D; Rohloff M; Fletcher J; Maatman TJ
    World J Urol; 2024 May; 42(1):347. PubMed ID: 38789638
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Waiting Times in prostate cancer Diagnosis and Treatment: A Ten-Year Experience in A Nigerian Teaching Hospital.
    Okeke CJ; Jeje EA; Ojewola RW; Ogunjimi MA; Ogbobe UU; Obi AO; Babalola RN
    West Afr J Med; 2024 Mar; 41(3):317-321. PubMed ID: 38788158
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3220.